Funicular Funds discloses 5.195M shares (6.7%) in Rein
Rein Therapeutics, Inc. ownership disclosure: Funicular Funds, LP (with related Cable Car Capital, LP and Jacob Ma‑Weaver) reports beneficial ownership of 5,195,000 shares of Common Stock, equal to 6.7% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Rein Therapeutics, Inc. ownership disclosure: Funicular Funds, LP (with related Cable Car Capital, LP and Jacob Ma‑Weaver) reports beneficial ownership of 5,195,000 shares of Common Stock, equal to 6.7% of the class. The filing states the position includes 420,000 warrants that are subject to a blocker provision preventing exercise that would increase beneficial ownership above 4.99%. The filing ties its percent calculation to 78,039,032 shares outstanding as reported in a Rule 424(b)(5) Prospectus filed May 4, 2026.
Key Figures
Key Terms
blocker provision regulatory
beneficial ownership financial
Rule 424(b)(5) Prospectus regulatory
warrants financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Funicular Funds report in Rein Therapeutics (RNTX)?
Does the Schedule 13G for RNTX disclose warrants held by the reporting parties?
Who is listed as the filing parties on the RNTX Schedule 13G?
What headquarters or principal address is shown for Rein Therapeutics in the filing?
How was the 6.7% ownership percentage calculated in the RNTX filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.